Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-WINDOW TRIAL for Endometrial Cancer
NCT07436793Phase 2Recruiting
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Jun 2026
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of megestrol, progesterone in endometrial cancer (EC), endometrial hyperplasia (EH), sponsored by New Mexico Cancer Research Alliance. Started Jun 2026; status: recruiting.
02
Drugs
megestrolprogesterone
03
Conditions
endometrial cancer (EC)endometrial hyperplasia (EH)
Beyond the preview
Go deeper on NCT07436793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07436793.